Gastric Cancer
4 competing products in clinical development for Gastric Cancer.
Pipeline by Phase
Phase 11
Phase 23
All Products (4)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Ramucirumab | Eli Lilly | Phase 2 | Completed | 52 |
| Infigratinib | LianBio | Phase 2 | Terminated | 44 |
| Infigratinib | LianBio | Phase 2 | UNKNOWN | 44 |
| Ramucirumab + MEDI4736 | Eli Lilly | Phase 1 | Completed | 33 |